Difference between revisions of "Campylobacter jejuni"
Line 36: | Line 36: | ||
===Burden of Disease=== | ===Burden of Disease=== | ||
It is estimated to affect over 2.4 million persons every year, or 0.8% of the population ([http://www.cdc.gov/nczved/divisions/dfbmd/diseases/campylobacter/ CDC]). <br /> | It is estimated to affect over 2.4 million persons every year, or 0.8% of the population ([http://www.cdc.gov/nczved/divisions/dfbmd/diseases/campylobacter/ CDC]). <br /> | ||
+ | |||
+ | ====Duration of infectiousness and disease==== | ||
+ | ====Symptomology==== | ||
+ | ====Latency==== | ||
+ | ====Asymptomatic Rates==== | ||
+ | ====Excretion Rates (see Exposure) ==== | ||
+ | ====Immunity==== | ||
===Microbiology=== | ===Microbiology=== |
Revision as of 14:38, 8 May 2012
Contents
Campylobacter jejuni
Host
Animals and humans
Transmission
Fecal-oral, ingestion of contaminated food or water, and the eating of raw meat
Case Fatality Ratio
Does not commonly cause death, it has been estimated that approximately 124 persons with Campylobacter infections die each year.
Case Fatality Ratio | Pathway/conditions | Population | References |
2.9 (95% CI: 1.9-40) | Infected domestically
Within first month following illness |
US | (Ternhag et al, 2005) |
0.3 (95% CI: 0.04-0.8) | Infected Abroad
Within first month following illness |
(Ternhag et al, 2005) |
Incubation Period
3-5 days or up to a week (Medscape)
Burden of Disease
It is estimated to affect over 2.4 million persons every year, or 0.8% of the population (CDC).
Duration of infectiousness and disease
Symptomology
Latency
Asymptomatic Rates
Excretion Rates (see Exposure)
Immunity
Microbiology
Gram-negative, spiral, and microaerophilic. Motile, with either unipolar or bipolar flagella, the organisms have a characteristic spiral/corkscrew appearance and are oxidase-positive
Environmental Survival
Recommended Dose Response Model
Dose response models for Campylobacter
Beta-Poisson, α is 0.14, N50 is 890.38
References
CDC Campylobacter Page
http://en.wikipedia.org/wiki/Campylobacter
http://emedicine.medscape.com/article/213720-overview#showall
Ternhag A, Torner An, Svensson A, Giesecke J, and Ekdahl K. (2005) Mortality following Campylobacter infection: a registry-based linkage study. BMC Infectious Diseases. 5:70. Full Text